Literature DB >> 8592666

Inhibition of pulmonary surfactant biophysical activity by cationic polyamino acids.

P M Bummer1, S Aziz, M N Gillespie.   

Abstract

PURPOSE: The purpose of this study is to investigate the interaction of cationic polyamino acids, polylysine and polyarginine, with rat pulmonary surfactant at the air/water interface.
METHODS: Surface pressure measurements of rat pulmonary surfactant in the presence and absence of polyamino acids were carried out in both dynamic and static modes.
RESULTS: In dynamic cycle studies, compression and expansion of adsorbed surfactant films in the presence of the cationic polyamino acids resulted in a delayed attainment of the plateau surface pressure. In area studies of spread surfactant films at constant surface pressure, cationic polyamino acids in the subphase resulted in an increase in film area. Increased film area was also observed when a polyamino acid was injected beneath films of dipalmitoyl-phosphatidylcholine/phosphatidylglycerol. In the presence of the cationic polyamino acids, the equilibrium surface pressure (at constant film area) of pulmonary surfactant was elevated in a concentration- and molecular weight-dependent manner.
CONCLUSIONS: These data indicate that the model cationic peptides interact with surfactant lipid, possibly electrostatically with phosphatidylglycerol. It is concluded that the surface activity of pulmonary surfactant is significantly inhibited by the presence of the polycations, possibly by the formation of a mixed lipid/polyamino acid film.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8592666     DOI: 10.1023/a:1016297118227

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  18 in total

1.  Phase separation in bimolecular mixed lipid membranes induced by polylysine.

Authors:  S Mittler-Neher; W Knoll
Journal:  Biochem Biophys Res Commun       Date:  1989-07-14       Impact factor: 3.575

2.  Interactions between plasma proteins and pulmonary surfactant: surface balance studies.

Authors:  K M Keough; C S Parsons; P T Phang; M G Tweeddale
Journal:  Can J Physiol Pharmacol       Date:  1988-09       Impact factor: 2.273

3.  A biophysical mechanism by which plasma proteins inhibit lung surfactant activity.

Authors:  B A Holm; G Enhorning; R H Notter
Journal:  Chem Phys Lipids       Date:  1988-11       Impact factor: 3.329

Review 4.  Lung surfactant.

Authors:  J L Harwood
Journal:  Prog Lipid Res       Date:  1987       Impact factor: 16.195

Review 5.  Biophysical behavior of lung surfactant: implications for respiratory physiology and pathophysiology.

Authors:  R H Notter
Journal:  Semin Perinatol       Date:  1988-07       Impact factor: 3.300

6.  Hydrophobic homopolymeric peptides enhance the biophysical activity of synthetic lung phospholipids.

Authors:  A R Venkitaraman; S B Hall; R H Notter
Journal:  Chem Phys Lipids       Date:  1990-03       Impact factor: 3.329

7.  Pulmonary surface film stability and composition.

Authors:  J N Hildebran; J Goerke; J A Clements
Journal:  J Appl Physiol Respir Environ Exerc Physiol       Date:  1979-09

8.  Surfactant disposition in rats with monocrotaline-induced pneumotoxicity.

Authors:  P M Bummer; J A Baughn; L P Sanders; K R Absher; W N O'Connor; J W Olson; M N Gillespie
Journal:  Toxicology       Date:  1994-05-31       Impact factor: 4.221

9.  Binding of basic peptides to acidic lipids in membranes: effects of inserting alanine(s) between the basic residues.

Authors:  M Mosior; S McLaughlin
Journal:  Biochemistry       Date:  1992-02-18       Impact factor: 3.162

10.  Reversible and irreversible inactivation of preformed pulmonary surfactant surface films by changes in subphase constituents.

Authors:  J D Amirkhanian; H W Taeusch
Journal:  Biochim Biophys Acta       Date:  1993-01-10
View more
  1 in total

1.  Mechanisms of polyelectrolyte enhanced surfactant adsorption at the air-water interface.

Authors:  Patrick C Stenger; Omer A Palazoglu; Joseph A Zasadzinski
Journal:  Biochim Biophys Acta       Date:  2009-01-27
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.